Spikevax 2025-26 (12Y up) syrg 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM39P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,632
Award facts
- Contract value 100% obligated
- $2,632.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 13, 2026, for $2,632.00 to supply Spikevax 2025-26 vaccine (12 years and up) in 0.5ml syringes. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. This delivery order is issued under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at approximately $1 billion through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal vendor with an extensive portfolio of medical product deliveries to the Defense Logistics Agency. The company's federal contracting demonstrates capability across diverse therapeutic domains, including vaccines, specialty medications, and medical supplies, serving military treatment facilities, veteran healthcare programs, and other federal medical institutions. This award continues the company's operational role under its DLA prime vendor contract, which provides flexible access to essential pharmaceutical commodities required by the Defense Health Agency, U.S. Coast Guard, and related government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM39P?
SPE2DR26FM39P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FM39P worth?
The government has obligated $2,632 on SPE2DR26FM39P.
Is contract SPE2DR26FM39P an order under another contract?
Yes. SPE2DR26FM39P is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM39P competed?
The extent of competition for SPE2DR26FM39P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award